Precose and Vasotec drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Precose (acarbose) and Vasotec (enalapril maleate). Common drug interactions include appetite decreased among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Precose and Vasotec. It is created by eHealthMe based on reports of 33 people who take the same drugs from the FDA, and is updated regularly.

What is Precose?

Precose has active ingredients of acarbose. eHealthMe is studying from 1,189 Precose users. Check the latest studies of Precose.

What is Vasotec?

Vasotec has active ingredients of enalapril maleate. It is often used in high blood pressure. eHealthMe is studying from 14,646 Vasotec users. Check the latest studies of Vasotec.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

33 people who take Precose and Vasotec together, and have interactions are studied.

What are the common drug interactions of Precose and Vasotec, by gender? *:

female:

Appetite decreased (decreased appetite occurs when you have a reduced desire to eat)
Aspartate aminotransferase increased
Blood albumin decreased
Blood bilirubin increased
Blood pressure decreased
Blood urea decreased
Cardiac disorder
Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
Cardiomegaly (increased size of heart than normal)
Circulatory collapse

male:

Dyspnoea (difficult or laboured respiration)
Chest pain
Appetite decreased (decreased appetite occurs when you have a reduced desire to eat)
Bile duct stone
Blood bilirubin increased
Blood creatinine increased
Cardiac failure congestive
Cholecystitis chronic (long lasting infection of gallbladder)
Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
Confusion

What are the common drug interactions of Precose and Vasotec, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Cardiac failure congestive

40-49:

Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
Myocardial ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased)
Oedema lower limb (fluid collection in tissue of lower leg)
Urine discolouration
Vomiting
Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
Arthralgia (joint pain)
Blood copper increased
Blood creatinine increased
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)

50-59:

Abdominal distension
Diabetic neuropathy (neuropathic disorders that are associated with diabetes mellitus)
Difficulty in walking
Drug effect decreased
Euphoric mood (excessively happy but may become angry or irritable)
Flatulence (flatus expelled through the anus)
Muscle contractions involuntary (uncontrolled muscle contraction)
Nervousness
Oedema (fluid collection in tissue)
Pain in limb

60+:

Dyspnoea (difficult or laboured respiration)
Chest pain
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Drug ineffective
Electrocardiogram abnormal
Hypotension (abnormally low blood pressure)
Insomnia (sleeplessness)
Nausea (feeling of having an urge to vomit)
Pulmonary oedema (fluid accumulation in the lungs)
Renal failure (kidney dysfunction)

* Approximation only. Some reports may have incomplete information.

Do you take Precose and Vasotec?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously